Remimazolam Tosilate

ApprovedSmall molecule

FFujian Shengdi Pharmaceutical Co., Ltd.

Remimazolam Tosilate is one of 46 small molecule programs targeting Sedation. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CognitionActive, not recruiting

CognitionApproved

Active, not recruiting

Competition

Competitive Landscape

191 competitors in Cognition

#DrugCompanyPhaseTrials

Remimazolam Tosilate

FFujian Shengdi Pharmaceutical Co., Ltd.

Approved

1 2

Estrace

Novo Nordisk

Preclinical

2 3

Activella

Eli Lilly

Preclinical

2 4

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Preclinical

1 5

Florinef

Alnylam Pharmaceuticals

Preclinical

1 6

Ozempic

Novo Nordisk

Preclinical

1 7

Resotran

Takeda

Preclinical

1 8

Veramyst

GSK

Preclinical

1 9

Galvus

Novartis

Preclinical

1 10

Marinol

Alnylam Pharmaceuticals

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sedation5 trials

A Study of Remimazolam Tosilate for Sedation in the ICU

Completed·FFujian Shengdi Pharmaceutical Co., Ltd.·Phase 2·NCT05152303·60 enrolled

A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 1/2·NCT05913336·24 enrolled

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 2·NCT05015361·108 enrolled

Show 2 more trials

A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 4·NCT06169995·31 enrolled

A Study of Remimazolam Tosilate for Sedation in the ICU

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 3·NCT06222294·214 enrolled

Remimazolam4 trials

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 3·NCT03779061·388 enrolled

A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 2·NCT03003884·153 enrolled

Effective Dose of Remimazolam Combined With Propofol in Painless Gastroscopy

Completed·SSichuan Provincial People's Hospital·N/A·NCT05876793·22 enrolled

Show 1 more trial

Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 3·NCT03425474·378 enrolled

Muscle Relaxants1 trial

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

Completed·HHarbin Medical University·N/A·NCT07035301·153 enrolled

General Anaesthesia1 trial

A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in Operations

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 2·NCT02406872·144 enrolled

Cognition1 trial

Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy

Recruiting·RRenJi Hospital·Phase 4·NCT05255211·90 enrolled

4 more indications

Bronchoscopy1 trial

A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 3·NCT04400201·330 enrolled

Dexmedetomidine1 trial

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Completed·SShiyou Wei·N/A·NCT05631028·115 enrolled

General Anesthesia1 trial

A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery

Completed·JJiangsu HengRui Medicine Co., Ltd.·Phase 3·NCT03921775·330 enrolled

Frail Elderly Patients1 trial

ED50 of Remimazolam for Anesthesia Induction in Frail Elderly Patients

Completed·TThe First Hospital of Hebei Medical University·N/A·NCT07467603·58 enrolled

Sources

References

[1]
ClinicalTrials.gov — 16 trial records for Remimazolam Tosilate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Remimazolam Tosilate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Remimazolam Tosilate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fujian Shengdi Pharmaceutical Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: FFujian Shengdi Pharmaceutical Co., Ltd.

Remimazolam Tosilate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Sedation5 trials

Remimazolam4 trials

Muscle Relaxants1 trial

General Anaesthesia1 trial

Cognition1 trial

Bronchoscopy1 trial

Dexmedetomidine1 trial

General Anesthesia1 trial

Frail Elderly Patients1 trial

References

Drug Info

Quick Facts

Related News